John Wiley & Sons today announced the launch of its KnowItAll 2020 software for drug classification using infrared analysis.
The Hoboken, N.J.-based company acquired the informatics KnowItAll spectroscopy software and spectral databases in April and is now debuting the new streamlined interface and tools to accelerate the analysis of unknown compounds, along with the drug classification capabilities, according to a news release.
KnowItAll 2020 includes new search parameters, streamlined spectral processing, quick classification for designer drugs and compounds, enhanced multi-technique searches, increased chemical intelligence, Drug Enforcement Agency controlled substance predictions and enhanced structure drawing.
“Coupled with over 2 million high-quality reference spectra, KnowItAll 2020 enhances Wiley Science Solutions – providing an integrated, one-stop solution for spectral identification and data management,” Wiley Research senior VP & chief product officer Jay Flynn said in the release. “We’re always looking for innovative solutions for researchers; and with KnowItAll’s simpler, more intuitive interface, and a new model derived from machine learning for spectral identification, researchers will be able to make faster and more accurate analyses.”
Filed Under: Drug Discovery, Drug Discovery and Development